Asahi Kasei seals Aicuris acquisition to bolster infectious disease pharma push
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Targets high-growth eye care expansion push
Manoj has over two decades of experience in healthcare operations and biomedical engineering
C-CAMP–Imperial College London partnership to boost biotech research, startup exchange, and translational innovation through a five-year collaboration
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Subscribe To Our Newsletter & Stay Updated